** Shares of IDT Australia IDT.AX rise 9.5% to A$0.115
** Stock hits its highest level since Nov 13, 2024
** The pharma manufacturer sees 1HFY25 revenue to jump by 82% to A$10.5 mln ($6.57 mln)
** Co says total unaudited quarterly revenue nearly doubles to A$5.3 mln from a year earlier
** Co says growth largely driven by significant increase in Advanced Therapies business
** Stock has gained 4.6%, YTD
($1 = 1.5972 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.